Marquette General Cancer Center

 

Myeloma

 

Study Name - SWOG S0777

 

Study Description -

A Randomized Phase III Trial of CC-5013 (Lenalidomide, NSC-703813) and Low Dose Dexamethasone (LLD) Versus Bortexomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction in Patients with Previously Untreated Multiple Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant.

 

IRB Open Date - 03/04/2011

 

Consent

 

 

 

Data Privacy Statement for Research Studies

<< Back